EUVIMEDEUVIMED entdecken
Crossref

Relaxin-3/RXFP1 Axis Regulates the Phenotypic Switch of Diabetic Vascular Smooth Muscle Cells by Inhibiting H3K18la-Mediated Egfr Transcription

Jiaxin Xue, Jingzhi Wang iD, Yuxin Yang iD, Xinfang Liang iD, Xiaoqi Liu iD, Siting Hong iD, Xiao Ma iD, Xiaohui Zhang iD

Arteriosclerosis, Thrombosis, and Vascular Biology · 2026

DOI: 10.1161/atvbaha.126.324338 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2026. Verfasst von Jiaxin Xue und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, China (J.X., J.W., Y.Y., X. Liang, X. Liu, S.H., X.Z.). Hauptthemen laut MEDLINE: Muscle, Smooth, Vascular, Myocytes, Smooth Muscle, Receptors, G-Protein-Coupled, Relaxin. Die Arbeit nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The phenotypic switching of vascular smooth muscle cells (VSMCs) is a critical pathophysiological mechanism of diabetic vascular remodeling. There is increasing evidence indicating that endogenous relaxin-3 exhibits cardiovascular effects, including vasodilation, reversal of ventricular remodeling, and attenuation of myocardial fibrosis. This study investigates the role of relaxin-3 as a key regulator in the phenotypic switching of VSMCs and elucidates its underlying mechanisms. METHODS: We generated a diabetic rat model to investigate the biological roles of relaxin-3 in diabetic vascular remodeling. Metabolomic profiling characterized relaxin-3-induced metabolic changes in VSMCs under high glucose treatment. Combined chromatin immunoprecipitation sequencing and RNA sequencing data were used to further investigate the gene regulatory mechanisms of relaxin-3 in the phenotypic switching of VSMCs and target genes regulated by H3K18la (histone H3 lysine 18 lactylation). RESULTS: Relaxin-3 and its receptor RXFP1 (relaxin family peptide receptor 1) were upregulated in diabetic human and rat aortas. Silencing of relaxin-3 or RXFP1 expression inhibited VSMC contractile phenotype protein expression and promoted VSMC proliferation. Relaxin-3 treatment mitigated the phenotypic switching of VSMCs via RXFP1, preserving VSMCs’ contractile phenotype. Further, relaxin-3 treatment lowered the glycolytic rate and lactate production during the phenotypic switching of VSMCs and decreased histone lactylation. Mechanistically, relaxin-3 suppressed LDHA (lactate dehydrogenase A)-mediated lactate production and H3K18la-mediated Egfr (epidermal growth factor receptor) transcription, and blocked PKM2 (pyruvate kinase M2) nuclear translocation, thereby preventing PKM2/β-catenin complex formation. CONCLUSIONS: Relaxin-3 alleviated the phenotypic switching of diabetic VSMCs through a dual mechanism: inhibiting lactate-mediated H3K18la and disrupting the intranuclear PKM2/β-catenin interaction, thereby preserving the contractile VSMC phenotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscle, Smooth, VascularMyocytes, Smooth MuscleReceptors, G-Protein-CoupledRelaxinHistonesErbB ReceptorsTranscription, GeneticDiabetes Mellitus, ExperimentalReceptors, PeptideVascular RemodelingNerve Tissue ProteinsDiabetic AngiopathiesAnimalsPhenotypeMaleHumansSignal TransductionCells, CulturedRats, Sprague-DawleyRatsCell Proliferation

Stichwörter der Autor:innen

diabetes mellitushistoneslactatesmuscle, smooth, vascularphenotypeprotein processing, post-translationalrelaxin

Substanzen

Receptors, G-Protein-CoupledRelaxinHistonesErbB ReceptorsEgfr protein, ratRxfp1 protein, ratReceptors, PeptideRLN3 protein, ratRXFP1 protein, humanNerve Tissue Proteins

Autor:innen und Institutionen

  • The Department of Cardiology, The First Affiliated Hospital of Harbin Medical University, China (J.X., J.W., Y.Y., X. Liang, X. Liu, S.H., X.Z.).
  • Department of Gastroenterology and Hepatology, The Second Affiliated Hospital of Harbin Medical University, China (X.M.).

ORCID-Profile: Jingzhi Wang, Yuxin Yang, Xinfang Liang, Xiaoqi Liu, Siting Hong, Xiao Ma, Xiaohui Zhang

Zitieren

APA

Xue, J., Wang, J., Yang, Y., Liang, X., Liu, X., Hong, S., Ma, X., & Zhang, X. (2026). Relaxin-3/RXFP1 Axis Regulates the Phenotypic Switch of Diabetic Vascular Smooth Muscle Cells by Inhibiting H3K18la-Mediated Egfr Transcription. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.126.324338

Vancouver

Xue J, Wang J, Yang Y, Liang X, Liu X, Hong S, et al. Relaxin-3/RXFP1 Axis Regulates the Phenotypic Switch of Diabetic Vascular Smooth Muscle Cells by Inhibiting H3K18la-Mediated Egfr Transcription. Arteriosclerosis, Thrombosis, and Vascular Biology. 2026. doi:10.1161/atvbaha.126.324338

BibTeX
@article{Xue2026,
  author = {Xue, Jiaxin and Wang, Jingzhi and Yang, Yuxin and Liang, Xinfang and Liu, Xiaoqi and Hong, Siting and Ma, Xiao and Zhang, Xiaohui},
  title = {Relaxin-3/RXFP1 Axis Regulates the Phenotypic Switch of Diabetic Vascular Smooth Muscle Cells by Inhibiting H3K18la-Mediated Egfr Transcription},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2026},
  doi = {10.1161/atvbaha.126.324338}
}
Kostenlos starten →